Try

Globus Medical Inc.

GMEDUnited States

117 filed reports · 522 financial concepts · 2 earnings calls · 0 media appearances

Filed reports

117 reports · Jun 2012 to Jun 2026

Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 246 guidance figures.

Report typeReportsFactsPeriods
Current · 8-KSEC EDGAR58242Jun 2013 to Jun 2026
Quarterly · 10-QSEC EDGAR427,006Sep 2012 to Jun 2026
Annual · 10-KSEC EDGAR135,486Dec 2013 to Dec 2025
Annual · 10-K/ASEC EDGAR3789Dec 2012 to Dec 2022
Quarterly · 10-Q/ASEC EDGAR185Jun 2012

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q28-KJun 30, 2026Aug 6, 20264Open
FY2026 Q210-QJun 30, 2026Aug 6, 2026478Open
FY2026 Q18-KMar 31, 2026May 7, 20264Open
FY2026 Q110-QMar 31, 2026May 7, 2026325Open
FY2025 Q48-KDec 31, 2025Feb 24, 20264Open
FY202510-KDec 31, 2025Feb 24, 2026969Open
FY2025 Q48-KDec 31, 2025Jan 7, 20264Open
FY2025 Q310-QSep 30, 2025Nov 6, 2025368Open
FY2025 Q38-KSep 30, 2025Nov 6, 20254Open
FY2025 Q28-KJun 30, 2025Aug 7, 20254Open
FY2025 Q210-QJun 30, 2025Aug 7, 2025200Open
FY2025 Q28-KJun 30, 2025Jul 21, 20254Open

Financial data

522 concepts · 13,608 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial495 concepts · 12,871 facts · Dec 2010 to Aug 2026

  • Net income loss78 · Dec 2010 to Jun 2026
  • Revenue78 · Dec 2010 to Jun 2026
  • Allocated share based compensation expense77 · Dec 2010 to Jun 2026
  • Comprehensive income net of tax77 · Dec 2010 to Jun 2026
  • Income tax expense benefit77 · Dec 2010 to Jun 2026
  • Operating income loss77 · Dec 2010 to Jun 2026
  • Other comprehensive income foreign currency transaction and translation adjustment net of tax portion attributable to parent77 · Dec 2010 to Jun 2026
  • Other comprehensive income loss net of tax portion attributable to parent77 · Dec 2010 to Jun 2026
  • Other nonoperating income expense77 · Dec 2010 to Jun 2026
  • Research and development expense77 · Dec 2010 to Jun 2026
  • Selling general and administrative expense77 · Dec 2010 to Jun 2026
  • Share based compensation arrangement by share based payment award options exercises in period total intrinsic value77 · Dec 2010 to Jun 2026
  • Depreciation depletion and amortization76 · Dec 2010 to Jun 2026
  • Increase decrease in accounts payable76 · Dec 2010 to Jun 2026
  • Increase decrease in accounts receivable76 · Dec 2010 to Jun 2026
  • Increase decrease in accrued income taxes payable76 · Dec 2010 to Jun 2026
  • Increase decrease in accrued liabilities and other operating liabilities76 · Dec 2010 to Jun 2026
  • Increase decrease in inventories76 · Dec 2010 to Jun 2026
  • Increase decrease in prepaid deferred expense and other assets76 · Dec 2010 to Jun 2026
  • Incremental common shares attributable to share based payment arrangements76 · Dec 2010 to Jun 2026
  • Inventory write down76 · Dec 2010 to Jun 2026
  • Net cash provided by used in financing activities76 · Dec 2010 to Jun 2026
  • Net cash provided by used in investing activities76 · Dec 2010 to Jun 2026
  • Net cash provided by used in operating activities76 · Dec 2010 to Jun 2026

Guidance5 concepts · 242 facts · Aug 2013 to Aug 2026

  • Revenue Guidance120 · Aug 2013 to Aug 2026
  • EPS (Diluted) Guidance116 · Aug 2013 to Aug 2026
  • EPS (Diluted) Growth Guidance2 · Jan 2016
  • EPS (Diluted) Guidance (Adjusted (non-GAAP))2 · Jul 2016
  • Revenue Growth Guidance2 · Jan 2016

Product1 concepts · 173 facts · Dec 2010 to Jun 2026

  • Revenue173 · Dec 2010 to Jun 2026

Geography1 concepts · 172 facts · Dec 2010 to Jun 2026

  • Revenue172 · Dec 2010 to Jun 2026

Segment20 concepts · 150 facts · Dec 2023 to Jun 2026

  • Amortization of intangible assets9 · Dec 2023 to Jun 2026
  • Business combination acquisition related costs9 · Dec 2023 to Jun 2026
  • Cost of goods and services sold depreciation9 · Dec 2023 to Jun 2026
  • Foreign currency transaction gain loss before tax9 · Dec 2023 to Jun 2026
  • Income loss from continuing operations before income taxes extraordinary items noncontrolling interest9 · Dec 2023 to Jun 2026
  • Labor and related expense9 · Dec 2023 to Jun 2026
  • Operating income loss9 · Dec 2023 to Jun 2026
  • Operating Segments9 · Dec 2023 to Jun 2026
  • Other research and development expense9 · Dec 2023 to Jun 2026
  • Other selling general and administrative expense9 · Dec 2023 to Jun 2026
  • Provision for other losses9 · Dec 2023 to Jun 2026
  • Revenue9 · Dec 2023 to Jun 2026
  • Business combination bargain purchase gain recognized amount8 · Dec 2023 to Jun 2026
  • Cost of goods and services sold (US GAAP)7 · Dec 2023 to Jun 2026
  • Interest income expense nonoperating net7 · Dec 2023 to Jun 2026
  • Segment reporting other item amount7 · Dec 2023 to Jun 2026
  • Amortization of inventory fair value step up6 · Sep 2024 to Jun 2026
  • Amortization of acquisition accounting fair value step up3 · Dec 2023 to Dec 2025
  • Interest income expense net2 · Sep 2024 to Sep 2025
  • Operating expenses (US GAAP)2 · Sep 2024 to Sep 2025

Segments

495 facts

Figures broken down by business line, region, product or another axis the company reports on.

Statement business segments2 members · 150 facts

  • Reportable119 · Dec 2023 to Jun 2026
  • Musculoskeletal Solutions And Enabling Technologies31 · Sep 2024 to Sep 2025

Product or servicesrt:ProductOrServiceAxis5 members · 99 facts

  • Emerging Technology42 · Jun 2017 to Sep 2025
  • Spine42 · Jun 2017 to Sep 2025
  • Enabling Technologies7 · Dec 2023 to Jun 2026
  • Musculoskeletal Solutions7 · Dec 2023 to Jun 2026
  • Neuromonitoring Services1 · Sep 2023

Statement geographicalsrt:StatementGeographicalAxis2 members · 94 facts

  • Non Us47 · Dec 2016 to Jun 2026
  • US47 · Dec 2016 to Jun 2026

Statement geographicalus-gaap:StatementGeographicalAxis3 members · 78 facts

  • US36 · Dec 2010 to Mar 2018
  • Non Us30 · Dec 2011 to Mar 2018
  • Segment Geographical Groups Of Countries Group One12 · Dec 2010 to Jun 2013

Product or serviceus-gaap:ProductOrServiceAxis4 members · 74 facts

  • Disruptive Technology35 · Dec 2010 to Dec 2017
  • Innovative Fusion35 · Dec 2010 to Dec 2017
  • Emerging Technology2 · Mar 2017 to Mar 2018
  • Spine2 · Mar 2017 to Mar 2018

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

  • Earnings-release commentary76 claims from 11 reports · Sep 2024 to Jun 2026
  • Management discussion (MD&A) commentary185 claims from 8 reports · Sep 2024 to Jun 2026
  • Risk-factor changes11 claims from 1 reports · Dec 2025
  • Risk factors116 risks from 2 annual reports · 2024 to 2025

Earnings calls

2 calls · May 2026 to Aug 2026

Transcripts with management claims and analyst questions, one per fiscal period.

  • FY2026 Q2Aug 6, 2026
  • FY2026 Q1May 7, 2026

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.

Globus Medical Inc. (GMED) data · FactIQ